Omega Diagnostics (ODX)

Company name:Omega Diagnostics Group Plc
EPIC:ODXTrading Currency:GBX
Market Sector:AIMPISIN:GB00B1VCP282
Market Segment:ASX1Share Type:DE
WWW Address:http://www.omegadiagnostics.co.uk/Description:ORD 4P
 Price Price Change [%] Bid Ask Open High Low Volume
 3.40 images.advfn.com/imagesnew/2/us/down -0.05 [-1.45] 3.30 3.50 3.45 3.45 3.40 1,610,748
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 8.08 237.69 -0.04 -1.20 - - - 12.88 - 2.25

Omega Diagnostics Key Figures

Key Figures
(at previous day's close)
Market Cap.8.08m
Shares In Issue237.69m
Prev. Close3.45
PE Ratio- 
Dividend Yield-%
EPS - basic-1.20p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-1.02p
Return On Equity (ROE)-8.89%
Operating Margin-405.27%
PEG Factor- 
EPS Growth Rate75.51%
Dividends PS Growth Rate-%
Net Debt1.49m
Gross Gearing23.61%
Quick Assets13.69m
Net Working Capital12.38m
Intangibles / Fixed Assets67.60%
Turnover PS3.67p
Pre-Tax Profit PS-14.89p
Retained Profit PS-0.89p
Cash PS2.45p
Net Cash PS0.96p
Net Tangible Asset Value PS *5.68p
Net Asset Value PS9.96p
Spread0.20 (5.71%) 

Omega Diagnostics Balance Sheet

%1$s Balance Sheet

Share Price Performance

Share Price Performance
Sample Period HighLow
1 week3.603.40
4 weeks4.053.05
12 weeks4.302.75
1 year12.882.25

Share Price Chart (5 years)

Share Price Chart (5 years)

Omega Diagnostics Historic Returns

%1$s Historic Returns
Giorni da oggi OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week3.50-0.10-2.863.401.643.56
4 weeks4.00-0.60-
12 weeks2.750.6523.642.752.173.71
26 weeks3.60-0.20-5.562.251.953.30
1 year10.75-7.35-68.372.252.924.63
3 years14.95-11.55-
5 years17.00-13.60-

Omega Diagnostics Key Management Ratios


Omega Diagnostics Investment Ratios

%1$s Investment Ratios
(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 0.32 
Tobin's Q Ratio (excl. intangibles)0.57 
Dividend Yield-%
Market-to-Book Ratio0.34 
Price-to-Pre-Tax Profit PS-0.23 
Price-to-Retained Profit PS-3.84 
Price-to-Cash Flow PS-3.34 
Price-to-Sales PS0.93 
Price-to-Net Tangible Asset Value PS0.60 
Price-to-Cash PS1.39 
Net Working Capital PS5.21 
Price Pct to Working Capital PS0.65%
Earnings Yield-%
Average PE18.79 
Years in average2 
PE to PE average-%

Omega Diagnostics Financial Ratios

%1$s Financial Ratios
(Leverage Ratios)
Debt Ratio13.72%
Debt-to-Equity Ratio0.16 
Debt-to-Equity Ratio (excl. Intgbl)0.28 
Debt-to-Equity Market Value0.47 
Net Gearing4.80%
Net Gearing (excl. Intangibles)7.15%
Gross Gearing23.61%
Gross Gearing (excl. Intangibles)35.16%
Gearing Under 1 Year11.46%
Gearing Under 1 Year (excl. Intgbl)17.06%
(Liquidity Ratios)
Net Working Capital to Total Assets39.94%
Current Ratio4.49 
Quick Ratio (Acid Test)3.86 
Liquidity Ratio1.64 
Cash & Equiv/Current Assets36.58%
(Solvency Ratios)
Enterprise Value6.02m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.91 
Total Debt/Sales0.84 
Total Debt/Pre-Tax Profit-0.21 
Total Debt7.32m
Total Debt/Net Current Assets0.59%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs7 
Beta coefficients
Beta (60-Mnth)Beta (36-Mnth)

Omega Diagnostics Operating Ratios

%1$s Operating Ratios
(Profitability Ratios)
Return On Capital Employed (ROCE)-129.01%
Return On Assets (ROA)-8.45%
Net Profit Margin-24.09%
Assets Turnover0.35 
Return On Equity (ROE)-8.89%
Return On Investment (ROI)-9.58%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-24.09%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.47 
Fixed Assets Turnover0.63 
Current Assets Turnover0.80 
Net Working Capital Turnover 
Inventory Turnover5.13 
(Other Operating Ratios)
Total Assets-to-Sales2.85 
Debt Collection Period265.13Days

Omega Diagnostics Dividends

Sorry No Data Available

Omega Diagnostics Fundamentals

Profit and Loss Account
 31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)31 Mar 2021 (GBP)
pre tax profit-6.91-51.02%1.1812.12%-8.30-84.51%-35.40-405.27%m
attributable profit-0.73-5.41%0.979.98%-6.93-70.56%-2.10-24.09%m
retained profit-0.73-5.41%0.979.98%-6.93-70.56%-2.10-24.09%m
eps - basic (p)-0.40 0.80 -4.90 -1.20 
eps - diluted (p)-0.40 0.80 -4.90 -1.20 
dividends per share- - - - 

Omega Diagnostics Balance Sheet

Balance Sheet
 31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)31 Mar 2021 (GBP)
 31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)31 Mar 2021 (GBP)
fixed assets fixed assets1.717.48%1.576.69%1.437.60%4.8815.74%m
intangibles intangibles15.0365.63%17.0472.61%11.4160.57%10.1832.86%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks1.827.96%1.004.26%1.176.21%2.247.22%m
debtors debtors4.2218.42%3.8616.45%4.8325.62%7.8625.38%m
cash & securities cash & securities0.120.51%--%--%5.8318.80%m
creditors - short creditors - short2.7612.03%2.319.82%2.3412.41%3.5511.46%m
creditors - long creditors - long3.0213.20%2.9812.69%2.8915.34%3.7612.15%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves17.1274.76%18.1977.49%13.6172.25%23.6776.39%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Omega Diagnostics Cash Flow Statement

%1$s Cash Flow Statement
31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)31 Mar 2021 (GBP)
Operating CF-0.830.370.55-2.42m
Pre-Financing CF-4.11-0.53-1.61-5.24m
Retained CF-0.620.010.035.83m

Omega Diagnostics Brokers

%1$s Brokers
HB Markets plcMarket Maker(MMF)Broker/DealerHOODHOPBGB2L
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC

Your Recent History
Omega Diag..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.